• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

因自我报告有恰加斯病病史而被推迟献血者:这是否降低了风险?

Donors deferred for self-reported Chagas disease history: does it reduce risk?

作者信息

Steele Whitney R, Hewitt Elizabeth H, Kaldun Anne M, Krysztof David E, Dodd Roger Y, Stramer Susan L

机构信息

Transmissible Disease Department, American Red Cross, Rockville, Maryland.

出版信息

Transfusion. 2014 Aug;54(8):2092-7. doi: 10.1111/trf.12590. Epub 2014 Mar 6.

DOI:10.1111/trf.12590
PMID:24601956
Abstract

BACKGROUND

Current Food and Drug Administration guidance specifies that all blood donors must be asked about a history of Chagas disease.

STUDY DESIGN AND METHODS

We identified all American Red Cross donors deferred for Chagas disease history from January 2000 to August 2011. Attempts were made to contact all deferred donors and invite them back for anti-Trypanosoma cruzi testing. After January 2007, all accepted donors (no Chagas history) were anti-T. cruzi tested.

RESULTS

Over the 12-year period (approx. 88 million donor presentations), 34 donors had a Chagas deferral. When contacted, seven reported risk (e.g., travel or residence in an endemic area, vector exposure) and six were anti-T. cruzi tested with one radioimmunoprecipitation assay (RIPA) positive. Six others had answered the question incorrectly. The remaining 21 could not be contacted but from the donor record it could be determined that 13 were Hispanic ethnicity or Spanish speaking and/or provided specific details of Chagas risk or disease.

CONCLUSIONS

In 12 years, only 28 potentially infected donors were identified using the Chagas question. Limited testing data suggest that few of these would have had serologic evidence of prior infection. In contrast, nearly 5 years of anti-T. cruzi screening identified 488 RIPA-positive donors, none of whom answered "yes" to the Chagas question. According to estimates in this study, the value of retaining the questionnaire in addition to testing translates to preventing the collection of 0.4 infected donors per billion. Thus, the Chagas history question has no meaningful value.

摘要

背景

美国食品药品监督管理局当前的指南规定,必须询问所有献血者是否有恰加斯病病史。

研究设计与方法

我们确定了2000年1月至2011年8月期间因恰加斯病病史而被延期献血的所有美国红十字会献血者。试图联系所有被延期的献血者,并邀请他们回来进行抗克鲁斯锥虫检测。2007年1月之后,所有接受检测的献血者(无恰加斯病病史)都进行了抗克鲁斯锥虫检测。

结果

在这12年期间(约8800万次献血者登记),有34名献血者因恰加斯病被延期。在联系后,7人报告有风险(如在流行地区旅行或居住、接触传播媒介),6人进行了抗克鲁斯锥虫检测,其中1人放射免疫沉淀试验(RIPA)呈阳性。另外6人回答问题错误。其余21人无法联系到,但从献血者记录中可以确定,13人是西班牙裔或说西班牙语,和/或提供了恰加斯病风险或疾病的具体细节。

结论

在12年里,通过询问恰加斯病问题仅识别出28名可能感染的献血者。有限的检测数据表明,其中很少有人会有既往感染的血清学证据。相比之下,近5年的抗克鲁斯锥虫筛查识别出488名RIPA阳性献血者,他们对恰加斯病问题均回答“否”。根据本研究的估计,除检测外保留问卷的价值在于每10亿次可防止采集到0.4名感染的献血者。因此,恰加斯病病史问题没有实际意义。

相似文献

1
Donors deferred for self-reported Chagas disease history: does it reduce risk?因自我报告有恰加斯病病史而被推迟献血者:这是否降低了风险?
Transfusion. 2014 Aug;54(8):2092-7. doi: 10.1111/trf.12590. Epub 2014 Mar 6.
2
[Chagas disease and blood transfusion: an emerging issue in non-endemic countries].[恰加斯病与输血:非流行国家中的一个新问题]
Transfus Clin Biol. 2011 Apr;18(2):286-91. doi: 10.1016/j.tracli.2011.02.006. Epub 2011 Mar 26.
3
Selective testing for Trypanosoma cruzi: the first year after implementation at Canadian Blood Services.对克氏锥虫的选择性检测:在加拿大血液服务实施后的第一年。
Transfusion. 2013 Aug;53(8):1706-13. doi: 10.1111/j.1537-2995.2012.03950.x. Epub 2012 Nov 12.
4
Assessment of a travel question to identify donors with risk of Trypanosoma cruzi: operational validity and field testing.评估一个旅行问题以识别有克氏锥虫感染风险的献血者:操作有效性和现场测试
Transfusion. 2008 Apr;48(4):755-61. doi: 10.1111/j.1537-2995.2007.01602.x. Epub 2008 Jan 7.
5
Testing blood donors for Chagas disease in the Paris area, France: first results after 18 months of screening.在法国巴黎地区对献血者进行查加斯病检测:筛查 18 个月后的初步结果。
Transfusion. 2010 Mar;50(3):575-83. doi: 10.1111/j.1537-2995.2009.02476.x. Epub 2009 Nov 9.
6
Epidemiologic and laboratory findings from 3 years of testing United States blood donors for Trypanosoma cruzi.3 年来美国献血者中进行克氏锥虫检测的流行病学和实验室发现。
Transfusion. 2012 Sep;52(9):1901-11. doi: 10.1111/j.1537-2995.2012.03569.x. Epub 2012 Feb 17.
7
Transfusion-associated Chagas disease (American trypanosomiasis) in Mexico: implications for transfusion medicine in the United States.墨西哥的输血相关恰加斯病(美洲锥虫病):对美国输血医学的启示
Transfusion. 2006 Feb;46(2):298-304. doi: 10.1111/j.1537-2995.2006.00715.x.
8
Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission.洛杉矶和迈阿密献血者中的克氏锥虫:献血者人口结构变化对血清阳性率的影响及对输血传播的意义。
Transfusion. 2002 May;42(5):549-55. doi: 10.1046/j.1537-2995.2002.00077.x.
9
Chagas disease and transfusion medicine: a perspective from non-endemic countries.恰加斯病与输血医学:非流行国家的视角
Blood Transfus. 2015 Oct;13(4):540-50. doi: 10.2450/2015.0040-15.
10
European strategies against the parasite transfusion risk.欧洲应对寄生虫输血风险的策略。
Transfus Clin Biol. 2005 Feb;12(1):1-4. doi: 10.1016/j.tracli.2004.12.001.

引用本文的文献

1
Bridging the critical gap between infectious disease blood donation screening and connection to healthcare services: the American Chagas disease example.弥合传染病献血筛查与医疗服务联系之间的关键差距:以美国恰加斯病为例。
J Public Health Policy. 2025 Mar;46(1):168-179. doi: 10.1057/s41271-024-00539-5. Epub 2024 Dec 18.
2
Chagas Disease in the United States: a Public Health Approach.美国的恰加斯病:公共卫生方法。
Clin Microbiol Rev. 2019 Nov 27;33(1). doi: 10.1128/CMR.00023-19. Print 2019 Dec 18.
3
Transfusion-Transmitted Infections: an Update on Product Screening, Diagnostic Techniques, and the Path Ahead.
输血传播感染:产品筛查、诊断技术及未来发展的最新进展。
J Clin Microbiol. 2018 Jun 25;56(7). doi: 10.1128/JCM.00352-18. Print 2018 Jul.
4
Update on Canine and Feline Blood Donor Screening for Blood-Borne Pathogens.犬猫血源性病原体献血筛查的最新进展
J Vet Intern Med. 2016 Jan-Feb;30(1):15-35. doi: 10.1111/jvim.13823.